SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-022902
Filing Date
2020-05-07
Accepted
2020-05-07 16:24:59
Documents
3
Period of Report
2020-05-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 Q1 2020 EARNINGS PRESS RELEASE 8-K snss-8k_20200507.htm 8-K 33392
2 EX-99.1 snss-ex991_6.htm EX-99.1 232129
3 GRAPHIC gemkfsxf3glx000001.jpg GRAPHIC 2773
  Complete submission text file 0001564590-20-022902.txt   270775
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51531 | Film No.: 20856844
SIC: 2834 Pharmaceutical Preparations